Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve

Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study

(2014) M. G. G. Kier et al.   ANNALS OF ONCOLOGY

Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia

(2014) C.G. Ruf et al.   Andrology

Sperm Concentration, Testicular Volume and Age Predict Risk of Carcinoma In Situ in Contralateral Testis of Men with Testicular Germ Cell Cancer

(2013) Camilla Nymann Rud et al.   JOURNAL OF UROLOGY

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

(2012) K-P Dieckmann et al.   BRITISH JOURNAL OF CANCER

MicroRNA expression profiling of carcinoma in situ cells of the testis

(2012) Guy Wayne Novotny et al.   ENDOCRINE-RELATED CANCER

EAU Guidelines on Testicular Cancer: 2011 Update

(2011) Peter Albers et al.   EUROPEAN UROLOGY

Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate

(2011) K. Almstrup et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Testosterone Production is Better Preserved After 16 than 20 Gray Irradiation Treatment Against Testicular Carcinoma In Situ Cells

(2009) Anne K. Bang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Management of the contralateral testicle in patients with unilateral testicular cancer

(2009) Eugene K. Lee et al.   WORLD JOURNAL OF UROLOGY

Evaluation of testicular biopsies for carcinomain situ: immunohistochemistry is mandatory

(2008) N. J. van Casteren et al.   INTERNATIONAL JOURNAL OF ANDROLOGY